Add to ORKGObjectives: To evaluate the ability of moxifloxacin to penetrate healthy brain barriers. Methods: Fifty patients received a single oral dose of 400 mg as an antimicrobial prophylaxis regimen for a short urological procedure under spinal anaesthesia. Serum and cerebrospinal fluid (CSF) were sampled at different time intervals post-drug intake and patients were divided into five groups, a
Ventriculostomy-associated infections in critically ill patients remain therapeutically challenging ...
In vitro levofloxacin exhibits both potent or intermediate activity against most of the pathogens fr...
Since clinical trials comparing the efficacies of different antibiotic regimens for treatment of bra...
Objectives: To evaluate the ability of moxifloxacin to penetrate healthy brain barriers. Methods: Fi...
Moxifloxacin cerebrospinal fluid (CSF) penetration was evaluated by obtaining full plasma and CSF ti...
Moxifloxacin cerebrospinal fluid (CSF) penetration was evaluated by obtaining full plasma and CSF ti...
In the past 20 years, an increased discrepancy between new available antibacterials and the emergenc...
A population pharmacokinetic analysis was performed to investigate the pharmacokinetics of moxifloxa...
The first line of treatment for tuberculosis (TB) consists of a combination of isoniazid (INH), rifa...
Moxifloxacin (MFX) is a useful agent in the treatment of multi-drug-resistant tuberculosis (MDR-TB)....
The killing and postantibiotic effects (PAE) of cefotaxime, ciprofloxacin, and gentamicin against Es...
A review of the world literature on the penetration (ratio of concentrations of cerebrospi-nal fluid...
Background: For an effective antimicrobial treatment, it is crucial that antibiotics reach sufficien...
Penetration of β-lactam antibiotics into cerebrospinal fluid and its relationship to inflammatory ma...
Central nervous system (CNS) antibiotic distribution was described mainly from cerebrospinal fluid d...
Ventriculostomy-associated infections in critically ill patients remain therapeutically challenging ...
In vitro levofloxacin exhibits both potent or intermediate activity against most of the pathogens fr...
Since clinical trials comparing the efficacies of different antibiotic regimens for treatment of bra...
Objectives: To evaluate the ability of moxifloxacin to penetrate healthy brain barriers. Methods: Fi...
Moxifloxacin cerebrospinal fluid (CSF) penetration was evaluated by obtaining full plasma and CSF ti...
Moxifloxacin cerebrospinal fluid (CSF) penetration was evaluated by obtaining full plasma and CSF ti...
In the past 20 years, an increased discrepancy between new available antibacterials and the emergenc...
A population pharmacokinetic analysis was performed to investigate the pharmacokinetics of moxifloxa...
The first line of treatment for tuberculosis (TB) consists of a combination of isoniazid (INH), rifa...
Moxifloxacin (MFX) is a useful agent in the treatment of multi-drug-resistant tuberculosis (MDR-TB)....
The killing and postantibiotic effects (PAE) of cefotaxime, ciprofloxacin, and gentamicin against Es...
A review of the world literature on the penetration (ratio of concentrations of cerebrospi-nal fluid...
Background: For an effective antimicrobial treatment, it is crucial that antibiotics reach sufficien...
Penetration of β-lactam antibiotics into cerebrospinal fluid and its relationship to inflammatory ma...
Central nervous system (CNS) antibiotic distribution was described mainly from cerebrospinal fluid d...
Ventriculostomy-associated infections in critically ill patients remain therapeutically challenging ...
In vitro levofloxacin exhibits both potent or intermediate activity against most of the pathogens fr...
Since clinical trials comparing the efficacies of different antibiotic regimens for treatment of bra...